You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Dermal Medical Countermeasures for Chemical Weapons Exposure
SBC: ZYMERON CORPORATION Topic: CBD161003The skin is the first line of defense against chemical warfare agents including nerve agents and toxic industrial chemicals, providing a possible barrier or delay to systemic distribution. Some chemicals also can act directly on the skin including the vesicants sulfur mustard and lewisite. Early and rapid skin decontamination is extremely important following exposure to CWAs and TICs because it de ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
3D Printing of Flexible Polymers for Respiratory Protection
SBC: ACTUATED MEDICAL, INC. Topic: CBD181001Department of Defense personnel must wear respiratory protection continuously when deployed in regions with the danger of chemical or biological attack. Manufacturing respirators/masks using conventional molding methods limits the features that can be designed into the protection. Additive manufacturing provides an ideal approach for manufacturing respirators. Additive Manufacturing enables the ab ...
SBIR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Medical Countermeasure Development for Viral Induced Encephalitis Using Single DomainAntibodies
SBC: ABZYME THERAPEUTICS LLC Topic: CBD161004Alphaviruses, infection with which may cause encephalitis and death, are recognized as potential biological warfare agents. There are noapproved medical countermeasures against Alphaviruses. In Phase I, using Abzymes proprietary in vivo Self-Diversifying Camelid SingleDomain Antibody Library (SDALib) platform, broadly reactive single domain camelid VHH antibodies against equine encephalitis viral ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Microfiber-Based Closures with Hermetic Sealing for Chem Bio Protective Garments
SBC: NANOGRIPTECH Topic: CBD13109Future engagements (especially with near-peer threats) present the possibility of a wide range of anticipated operational situations involving the presence of chemical threat agents. With this, deployment of Military Working Dogs (MWDs) is likely. This creates a situational awareness that MWDs are potentially at risk from exposure to a wide range of hazardous chemicals. Potential threat agents inc ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense